Her main research interests are rare bone disorders of childhood. These span bone fragility disorders (Osteogenesis Imperfecta or brittle bone disease, hypophosphatasia) to high bone mass disorders (Osteopetrosis or marble bone disease); a range of growth and bone disorders: hormone disorders, skeletal dysplasias, achondroplasia, calcium and phosphate disorders (such as XLH, Vitamin D disorders and placental calcium transfer disorders).

Current research includes Principal Investigator for several rare bone disease trials: 1. Prospective, multicenter study on Denosumab in children with osteogenesis imperfecta 2. An observational, longitudinal, long-term registry of patients with Hypophosphatasia (HPP) 3. International Registry for XLH 4. Natural history of children with Achondroplasia study; and active clinical research projects with international collaborations exploring mechanisms in osteopetrosis and rare forms of osteogenesis imperfecta and other bone fragility disorders.